 |
|
Prognostic Factors in Meningococcal DiseaseDevelopment of a Bedside Predictive Model and Scoring System
Nicolau Barquet, MD;
Pere Domingo, MD;
Joan A. Caylà, MD;
Juliá González, MD;
Carlos Rodrigo, MD;
Pedro Fernández-Viladrich, MD;
Fernando A. Moraga-Llop, MD;
Francesc Marco, MD;
Julio Vázquez, MD;
Juan A. sáez-Nieto, MD;
Julio Casal, MD;
Jaume Canela, MD;
Màrius Foz, MD
JAMA. 1997;278(6):491-496.
Abstract
| |
Context.
—Meningococcal disease is associated with significant morbidity and mortality. Development of a prognostic model based on clinical findings may be useful for identification and management of patients with meningococcal infection.
Objectoves.
—To construct and validate a bedside model and scoring system for prognosis in meningococcal disease.
Design.
—Prospective, population-based study.
Setting.
—Twenty-four hospitals in the metropolitan area of Barcelona, Spain.
Patients.
—A total of 907 patients with microbiologically proven meningococcal disease. Patients diagnosed with meningococcal disease from 1987 through 1990 were used to develop the prognostic model, and those diagnosed in 1991 and 1992 were used to validate it.
Outcome Measures.
—Clinical independent prognostic factors for mortality in meningococcal disease. The association between outcome and independent prognostic factors was determined by logistic regression analysis. A scoring system was constructed and tested using receiver operating characteristic curves.
Results.
—Among 624 patients in the derivation set, 287 (46%) were male, the mean age was 12.4 years, and 34 patients (5.4%) died. Among 283 patients in the validation set, 124 (43.8%) were male, the mean age was 12.7 years, and 17 patients (6.0%) died. In multivariate analysis, independent predictors of death were hemorrhagic diathesis (odds ratio [OR], 101; 95% confidence interval [CI], 30-333), focal neurologic signs (OR, 25; 95% CI, 7-83), and age 60 years or older (OR, 10; 95% CI, 3-34), whereas receipt of adequate antibiotic therapy prior to admission was associated with reduced likelihood of death (OR, 0.09; 95% CI, 0.02-0.4). Hemorrhagic diathesis was scored with 2 points, presence of focal neurologic signs with 1 point, age of 60 years or older with 1 point, and preadmission antibiotic therapy was scored as -1. The clinical scores of -1, 0,1,2, and 3 or more points were associated with a probability of death of 0%, 2.3%, 27.3%, 73.3%, and 100%, respectively.
Conclusions.
—Hemorrhagic diathesis, focal neurologic signs, and age of 60 years or older were independent predictors of death in meningococcal disease, whereas receipt of adequate antibiotic therapy was associated with a more favorable prognosis. The scoring system presented is simple, is based on findings readily available at the bedside, and may be useful to help guide aggressive therapy.
Author Affiliations
for the Barcelona Meningococcal Disease Surveillance Group
From the CAP Gracia, Institut Català de la Salut (Dr Barquet), Hospital de la Santa Creu i Sant Pau (Dr Domingo), Institut Municipal de la Salut (Dr Caylá), Hospital Clinic (Drs González and Marco), Hospital Infantil Vall d' Hebron (Dr Moraga-Llop), Departament de Salut Pública i Legislació Sanitària (Dr Canela), Barcelona, Spain; Hospital Germans Trias i Pujol (Drs Rodrigo and Foz), Badalona, Spain; Hospital de Bellvitge (Dr Fernández-Viladrich), L' Hospitalet de Llobregat, Spain; Laboratorio de Referencia de Meningococos (Drs Vázquez, Sáez-Nieto, and Casal), Centro Nacional de Microbiología, Virología e Inmunología Sanitarias, Madrid, Spain.
Footnotes
A complete list of the participating centers and other members of the Barcelona Meningococcal Disease Surveillance Group not listed as authors appears at the end of this article.
Reprints: Nicolau Barquet, MD, Calvet, 47-49, Entlo A, 08021 Barcelona, Spain (e-mail: barquet@tresnet.com).
 CiteULike  Connotea  Del.icio.us  Digg  Reddit  Technorati  Twitter
What's this?
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
Effectiveness of antibiotics given before admission in reducing mortality from meningococcal disease: systematic review.
Hahne et al.
BMJ 2006;332:1299-1303.
ABSTRACT
| FULL TEXT
On Meningococcal Disease, Its Prognosis, and Undernotification of the Public Health Service
Nonell et al.
Arch Intern Med 2000;160:2219-2220.
FULL TEXT
Oral Antibiotics and Outcome in Meningococcemia
Radetsky et al.
Arch Intern Med 2000;160:2220-2223.
FULL TEXT
Update on Meningococcal Disease with Emphasis on Pathogenesis and Clinical Management
van Deuren et al.
Clin. Microbiol. Rev. 2000;13:144-166.
ABSTRACT
| FULL TEXT
Meningococcal Disease in a Large Urban Population (Barcelona, 1987-1992): Predictors of Dismal Prognosis
Barquet et al.
Arch Intern Med 1999;159:2329-2340.
ABSTRACT
| FULL TEXT
Prognostic Factors in Meningococcal Disease
Radetsky
JAMA 1997;278:1658-1658.
ABSTRACT
|
